Seres Therapeutics Inc Annual Shareholders Meeting Transcript
Good morning, everyone. I'm Tom DesRosier, Executive Vice President.
Good morning. This is Caroline Holda. I'm going to take over as I don't hear Tom's voice. I am the Assistant Secretary and Assistant General Counsel of Seres Therapeutics and the Deputy Chairperson of today's meeting. I'm very happy to welcome you to our 2020 Annual Meeting of Shareholders, which we are holding virtually in light of the COVID-19 pandemic.
Before the meeting is called to order, I'd like to introduce you to the members of the Board and the other Executive Officers of the company who are on the webcast today. From the Board, we have Eric Shaff, President and Chief Executive Officer of Seres; Stephen Berenson, Chairman of the Board; Dennis Ausiello; Grégory Behar; Paul Biondi; Willard Dere; Kurt Graves; Richard Kender; and Meryl Zausner.
From the company, we also have John Aunins, our Chief
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |